KALA - Kala Pharmaceuticals' (KALA) CEO Mark Iwicki on Q3 2021 Results - Earnings Call Transcript
Kala Pharmaceuticals, Inc. (KALA) Q3 2021 Earnings Conference Call November 15, 2021 08:30 AM ET Company Participants Jill Steier – Executive Director, Investor Relations and Corporate Communications Mark Iwicki – Chairman, President and Chief Executive Officer Kim Brazzell – Chief Medical Officer Todd Bazemore – Chief Operating Officer Mary Reumuth – Chief Financial Officer Conference Call Participants Andreas Argyrides – Wedbush Christopher Neyor – JPMorgan François Brisebois – Oppenheimer Chris Howerton – Jefferies Presentation Operator Good morning, and welcome to Kala Pharmaceuticals Conference Call to review its Third Quarter Financial Results and the Acquisition of Combangio. Please note that the slide presentation that was designed to accompany this conference call is available on Kala's website, kalarx.com, as well as through the webcast player. At this time all participants are in a listen-only mode. Following management's prepared remarks, the Q&A session will be held. As a reminder, this call is being
For further details see:
Kala Pharmaceuticals' (KALA) CEO Mark Iwicki on Q3 2021 Results - Earnings Call Transcript